# China Merchants Health

> China Merchants Health is a VC fund in Nanshan backing Medical and Biotechnology. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Nanshan, China
- Total investments: 9
- Last investment: Feb 2024
- Lead investor: 78%
- Last updated: Aug 2026
- Website: https://www.cm-health.com

China Merchants Health is a comprehensive enterprise with a diverse range of businesses. It specializes in transportation and logistics, comprehensive finance, comprehensive urban and park development, and rising businesses like health and testing.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 56% |
| Biotechnology | 4 | 44% |
| Health Care | 3 | 33% |
| Manufacturing | 3 | 33% |
| Therapeutics | 2 | 22% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 33% |
| Series C | 3 | 33% |
| Series B | 2 | 22% |
| Venture - Series Unknown | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 8 | 89% |
| Japan | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MingDu Intelligent | MingDu Intelligent is a medical intelligent manufacturing service provider. |  | Series C | Feb 29, 2024 |  |
| NeuroDawn Pharmaceutical | NeuroDawn Pharmaceutical develops new drugs that are designed to treat central nervous system diseases. | $14.7M | Series A | Feb 08, 2023 |  |
| Onehealthpro | Onehealthpro is a health-oriented enterprise that provides medical and health protection services to overseas builders. |  | Venture - Series Unknown | Jan 01, 2023 |  |
| Nuwacell | Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products. |  | Series A | Sep 13, 2022 |  |
| Porton Advanced Solutions | Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services. | $80M | Series B | Aug 21, 2022 |  |
| Wellgrow Technology | Wellgrow Technology is a developer of in vitro diagnostic medical equipment and reagents for life sciences, clinical medical diagnostics, and food safety. |  | Series B | Jan 25, 2022 |  |
| Shanghai Shangyong Technology | Ins. For Renascence focuses on providing solutions and technical service for internet insurance. | $15.4M | Series C | Aug 26, 2021 |  |
| Stemirna | Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, andgenetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients. | $187.4M | Series C | Jun 03, 2021 |  |
| accunome | accunome is a high-tech enterprise focusing on the in vitro diagnostic industry. |  | Series A | Jun 03, 2021 |  |

9 of 9 investments shown.

## Co-investors
- [Advantech Capital](https://shizune.co/investors/profile/advantech-capital) — VC Fund, 1 deal together
- [Beijing Shenzhen Sai Fund](https://shizune.co/investors/profile/beijing-shenzhen-sai-fund) — VC Fund, 1 deal together
- [BlackRock](https://shizune.co/investors/profile/blackrock) — VC Fund, 1 deal together
- [China Industrial Asset Management](https://shizune.co/investors/profile/china-industrial-asset-management-ltd) — VC Fund, 1 deal together
- [China Merchants Venture Capital](https://shizune.co/investors/profile/china-merchants-capital) — VC Fund, 1 deal together
- [China Merchants Securities](https://shizune.co/investors/profile/china-merchants-securities) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does China Merchants Health invest in?

China Merchants Health invests primarily in Medical, Biotechnology and Health Care startups, most often at Series A and Series C stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did China Merchants Health last invest?

The most recent investment recorded for China Merchants Health closed in Feb 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co